Cardiovascular Disease in Estonia: Why This Matters
Estonia is among the European countries with the highest cardiovascular mortality. According to the National Institute for Health Development, cardiovascular diseases (CVD) are the leading cause of death in Estonia, accounting for over 50% of all deaths — higher than in most Western European countries.
Omega-3 fatty acids and vitamin D are two micronutrients epidemiologically linked to reduced cardiovascular risk — and both are widely deficient in Estonia. Unocardio 1000 combines both.
TL;DR: Unocardio 1000 by Igennus Healthcare delivers ~1000 mg EPA+DHA + 1000 IU vitamin D3 per capsule. Dose matters: the VITAL trial (1g EPA+DHA, healthy adults) did not significantly reduce CVD events, but REDUCE-IT (4g EPA, high-risk patients) showed a 25% reduction. Unocardio 1000 is a good starting point for high-risk individuals, but maximum cardiovascular benefit requires 2–4 capsules per day and physician guidance.
What Is Unocardio 1000 and Who Makes It
Igennus Healthcare is a UK-based supplement manufacturer specializing in high-concentration omega-3 products. Their Unocardio brand is specifically designed for the cardiovascular health segment.
Unocardio 1000 composition (1 capsule):
| Component | Amount |
|---|---|
| Total fish oil | ~1300 mg |
| EPA (eicosapentaenoic acid) | ~600 mg |
| DHA (docosahexaenoic acid) | ~400 mg |
| Total EPA+DHA | ~1000 mg |
| Vitamin D3 (cholecalciferol) | 1000 IU (25 µg) |
| Tocopherols (antioxidant) | Vitamin E |
The EPA+DHA content per capsule (1000 mg) is two to three times higher than a standard fish oil capsule (300–500 mg).
Why Omega-3 + D3 Is a Logical Combination
This is not an arbitrary pairing. Both omega-3 fatty acids and vitamin D influence the same cardiovascular pathways:
Omega-3 mechanisms:
- Reduces triglyceride synthesis in the liver (EPA + DHA inhibit VLDL synthesis)
- Lowers inflammatory markers (IL-6, CRP)
- Reduces platelet aggregation
- Modestly lowers blood pressure (Mozaffarian & Wu, 2011)
Vitamin D3 mechanisms:
- Vitamin D receptors exist in heart muscle, vascular endothelium, and macrophages
- Low vitamin D is associated with hypertension, heart failure, and increased CVD risk (Pilz et al., 2008)
- Modulates renin-angiotensin-aldosterone system regulation
- In Estonia, vitamin D deficiency is near-universal October through April
Two complementary effects in one capsule:
Since both are commonly deficient in Estonians and both influence cardiovascular health, their combination is particularly relevant in this population.
Dose Matters: VITAL vs REDUCE-IT
This is one of the most important lessons from omega-3 research: not all doses are equivalent.
VITAL Trial (Manson et al., 2019)
N = 25,871 healthy adults, 5.3 years follow-up
- Omega-3 dose: 1 g EPA+DHA per day
- Result: No statistically significant reduction in the primary endpoint of CVD events
- However: 28% fewer fatal myocardial infarctions in the omega-3 group vs placebo
- However: Among participants without prior heart disease, fewer CVD events were observed
REDUCE-IT Trial (Bhatt et al., 2019)
N = 8,179 high-CVD-risk patients (on statin therapy with elevated triglycerides)
- Omega-3 dose: 4 g EPA per day (high-purity prescription icosapentaenoic acid / Vascepa)
- Result: 25% reduction in major CVD events
- This is a clinically meaningful result
Practical conclusions:
| EPA+DHA Dose Per Day | Population | Result |
|---|---|---|
| 1 g | Healthy adults | Modest benefit, significance marginal |
| 2–4 g | High CVD risk, elevated triglycerides | Meaningful benefit (TG -20–30%) |
| 4+ g | High CVD risk + statin therapy | Major benefit (REDUCE-IT) |
Unocardio 1000 (1000 mg EPA+DHA per capsule) is a good starting point — but for cardiovascular conditions, 2–4 capsules per day are often needed.
Triglyceride Lowering: How It Works
Omega-3 is one of the most effective natural triglyceride-lowering agents. Harris (2007) meta-analysis showed:
- 2 g EPA+DHA per day: triglycerides reduced by 15–20%
- 4 g EPA+DHA per day: triglycerides reduced by 25–30%
- The effect is dose-linear
- Benefit is most pronounced when baseline values are elevated (>3 mmol/L)
Mechanisms:
1. EPA + DHA inhibit fatty acid synthesis in the liver
2. Increase fatty acid oxidation
3. Reduce secretion of VLDL lipoproteins
Important caveat: Omega-3 can modestly raise LDL cholesterol ("bad cholesterol") in some people. If LDL is already elevated, discuss with your doctor.
Vitamin D's Role: Why 1000 IU
Unocardio 1000 contains 1000 IU vitamin D3 per capsule. In Estonia, this is particularly relevant:
- Vitamin D deficiency in winter is near-universal in Estonia
- Population studies show that >70% of Estonians have vitamin D levels below 50 nmol/L from October to April
- Pilz et al. (2008) in a study of 3,200 individuals found that low vitamin D was associated with ~2× greater CVD mortality risk
Is 1000 IU enough? It depends on baseline levels. General guidance:
- Adults with limited sun exposure: 2000–4000 IU per day
- Unocardio 1000 provides 1000 IU — a good addition, but during winter, separate additional vitamin D may be needed
Who Should Choose Unocardio 1000
Ideal users:
- People with elevated triglycerides (>1.7 mmol/L) seeking cardiac support
- Those with cardiovascular risk factors (hypertension, overweight, smoking, family history)
- People already on statin therapy looking to add omega-3 support (consult your doctor)
- Post-MI patients in follow-up care (under physician guidance)
- Estonians who have both vitamin D and omega-3 deficiency — which is practically every adult in winter
Consider other options if:
- You need >3 g EPA+DHA per day — prescription drugs are more effective and often cheaper at that dose
- You are pregnant or planning pregnancy — consult your doctor for specific recommendations
- You use anticoagulants (warfarin, etc.) — mandatory physician consultation before starting
Interactions and Safety: What to Know
Statins
Omega-3 combined with statins is generally safe and logical — both support cardiovascular health through different mechanisms. The REDUCE-IT trial was conducted in patients on statin therapy.
Anticoagulants (Blood Thinners)
At high doses (>3 g EPA+DHA per day), omega-3 can reduce platelet aggregation and increase bleeding risk. If you take warfarin, high-dose aspirin, or newer anticoagulants (rivaroxaban, apixaban), discuss with your doctor before starting.
Surgery
Stop omega-3 two weeks before elective surgery, as it may prolong bleeding time.
Liver Disease
People with liver disease should use omega-3 with caution — the liver metabolizes fatty acids, and large doses may increase the load.
How to Use the Product
Recommended dose: 1–4 capsules per day with food
Best timing: with a fat-containing meal (lunch or dinner). Absorption with fat is up to 50% better.
Dosing by goal:
| Goal | Capsules Per Day | Total EPA+DHA |
|---|---|---|
| General cardiac maintenance | 1 | 1000 mg |
| Elevated triglycerides | 2–3 | 2000–3000 mg |
| Doctor-recommended high dose | 4 | 4000 mg |
| Drug interactions — physician monitoring | >3 | Consult doctor |
Comparison With Other Cardiovascular Omega-3 Products
| Product | EPA+DHA/Capsule | D3 | Price €/90 caps | IFOS |
|---|---|---|---|---|
| Unocardio 1000 (Igennus) | ~1000 mg | 1000 IU | €35–50 | Not disclosed |
| NOW Ultra Omega-3 | 750 mg | No | €18–25 | 5-star |
| Vascepa (Prescription) | 840 mg pure EPA | No | €100–200 | Prescription |
| Standard fish oil | 300 mg | No | €8–15 | Varies |
Unocardio 1000 is optimized for the cardiovascular user — high EPA+DHA with D3 in one capsule. It is more convenient than combining separate products, though somewhat more expensive.
Common Mistakes and Fixes
Mistake 1: One capsule per day is enough to reduce triglycerides
1000 mg EPA+DHA per day may not be sufficient for a meaningful triglyceride reduction — most studies use 2–4 g. Discuss optimal dosing with your doctor.
Mistake 2: Expecting results too quickly
Triglyceride changes with omega-3 appear over 4–8 weeks. Plan blood work review 2–3 months after starting.
Mistake 3: Choosing fish oil without D3 when vitamin D is low
For Estonians, a product like Unocardio 1000 is particularly practical in winter — two deficiencies addressed in one product.
Mistake 4: Stopping prescription drugs to switch to omega-3
Omega-3 supplements complement medications, they do not replace them. Statins, blood pressure medications, and anticoagulants each serve distinct purposes.
Frequently Asked Questions
Is Unocardio 1000 suitable for primary heart attack prevention?
Evidence in healthy people (VITAL) is weaker — 1 g per day did not significantly reduce CVD events. If you are healthy but want general cardiovascular support, one capsule per day is a reasonable choice.
What if my triglycerides are persistently above 3 mmol/L?
This requires medical evaluation. Omega-3 may be part of the treatment plan, but triglycerides this high often need dietary changes and possibly fibrate therapy.
Is 1000 IU of D3 enough?
It is sufficient as a supplement, but may not be enough to correct a deficiency. If your vitamin D level is below 25 nmol/L, you need a higher dose (4000–5000 IU) under medical supervision. Once levels normalize, 1000 IU per day is a reasonable maintenance dose.
Is this product suitable for vegans?
No — fish oil and fish gelatin capsules are not suitable for vegans.
Estonia Context: Why Cardiovascular Health Is Especially Important Here
Estonia has one of Europe's highest cardiovascular mortality rates. Contributing factors:
- High meat consumption and traditionally fat-rich diet
- Alcohol consumption above the European average
- Relatively high smoking prevalence
- A significant share of the population that accesses healthcare infrequently
- Fatty fish consumption is lower than in Scandinavian countries
Omega-3 and vitamin D supplementation is among the cheapest and safest interventions for reducing cardiovascular risk — especially when dietary fish oil intake is low. A product like Unocardio 1000 is well-positioned for this purpose.
References
1. Mozaffarian D, Wu JH. (2011). Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. Journal of the American College of Cardiology, 58(20), 2047–2067.
2. Harris WS. (2007). Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacological Research, 55(3), 217–223.
3. Manson JE, Cook NR, Lee IM, et al. (2019). Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. New England Journal of Medicine, 380(1), 23–32.
4. Bhatt DL, Steg PG, Miller M, et al. (2019). Cardiovascular risk reduction with icosapentaenoic acid for hypertriglyceridemia. New England Journal of Medicine, 380(1), 11–22.
5. Pilz S, März W, Wellnitz B, et al. (2008). Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study. Journal of Clinical Endocrinology and Metabolism, 93(10), 3927–3935.
6. Calder PC. (2015). Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochimica et Biophysica Acta, 1851(4), 469–484.
Summary
Unocardio 1000 is a well-designed product with high EPA+DHA (1000 mg per capsule) combined with vitamin D3 (1000 IU) — a logical pairing that addresses two common deficiencies in Estonians simultaneously. The evidence for higher omega-3 doses (2–4 g) in reducing cardiovascular risk is strong, particularly in patients with elevated triglycerides.
But dose matters: one capsule per day is a good maintenance dose, but therapeutic goals often require 2–4 capsules. Speak with your doctor — especially if you take statins, anticoagulants, or have a diagnosed cardiovascular condition.
See also:
- Ultra Omega-3 Concentrate: Why Potency Matters
- NOW Foods Ultra Omega-3: Honest Product Review
- Vitamin D: Estonia Context, Dosages, and Deficiency Symptoms
See also:



